INS and Hyperglycemia: The effects of short-term tacrolimus exposure promoting hyperglycaemia and compensatory hyperinsulinemia transition to the pseudo-normalisation of insulin, indicative of the loss of insulin secretory capacity, with evidence of β-cell death [64].